Quratis Inc

XKRX:348080 (Korea (the Republic of))  
â‚© 603.00 (+4.33%) Jan 3
At Loss
P/B:
1.38
Market Cap:
â‚© 34.95B ($ 23.77M)
Enterprise V:
â‚© 56.93B ($ 38.71M)
Volume:
262.07K
Avg Vol (2M):
517.87K
Trade In:
Volume:
262.07K
At Loss

Business Description

Description
Quratis Inc operates as a developer of vaccines and therapies designed to treat tuberculosis. The company develops youth and adults tuberculosis vaccines, messenger ribonucleic acids, and other related immune-related vaccines.
Name Current Vs Industry Vs History
Cash-To-Debt 0.02
Equity-to-Asset 0.4
Debt-to-Equity 1.2
Debt-to-EBITDA -1.49
Piotroski F-Score 2/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -6.87
Distress
Grey
Safe
Beneish M-Score 6.55
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 56.95
9-Day RSI 49.75
14-Day RSI 45.43
6-1 Month Momentum % -44.86
12-1 Month Momentum % -70.64

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 0.3
Quick Ratio 0.2
Cash Ratio 0.03
Days Inventory 48.47
Days Sales Outstanding 317.44
Days Payable 3.25

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -27
Shareholder Yield % 2.74

Profitability Rank

Name Current Vs Industry Vs History
Gross Margin % -3662.57
Operating Margin % -5262.86
Net Margin % -6439.5
FCF Margin % -4128.4
ROE % -73.07
ROA % -36.97
ROIC % -29.12
ROC (Joel Greenblatt) % -41.11
ROCE % -45.97

GF Value Rank

Name Current Vs Industry Vs History
PS Ratio 78.86
PB Ratio 1.38
Price-to-Tangible-Book 1.43
EV-to-EBIT -2.92
EV-to-EBITDA -3.8
EV-to-Revenue 176.84
EV-to-FCF -4.28
Earnings Yield (Greenblatt) % -34.25
FCF Yield % -38.03
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016

Quratis Inc Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil â‚©) 321.952
EPS (TTM) (â‚©) -462
Beta 0
Volatility % 48.15
14-Day RSI 45.43
14-Day ATR (â‚©) 51.844973
20-Day SMA (â‚©) 590.15
12-1 Month Momentum % -70.64
52-Week Range (â‚©) 521 - 2320
Shares Outstanding (Mil) 57.96

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 2
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Quratis Inc Filings

Filing Date Document Date Form
No Filing Data

Quratis Inc Stock Events

Financials Calendars
Event Date Price(â‚©)
No Event Data

Quratis Inc Frequently Asked Questions

What is Quratis Inc(XKRX:348080)'s stock price today?
The current price of XKRX:348080 is â‚©603.00. The 52 week high of XKRX:348080 is â‚©2320.00 and 52 week low is â‚©521.00.
When is next earnings date of Quratis Inc(XKRX:348080)?
The next earnings date of Quratis Inc(XKRX:348080) is .
Does Quratis Inc(XKRX:348080) pay dividends? If so, how much?
Quratis Inc(XKRX:348080) does not pay dividend.

Press Release

Subject Date
No Press Release